Coloverin SR Extended-Release Capsules: Mechanism, Dosages, and Safe IBS Treatment

✔️ Medically Reviewed by: Dr. Ahmad Baker, PharmD

Coloverin SR – The Comprehensive Guide to Treating Irritable Bowel Syndrome and Spasms

An integrated medical guide on Coloverin SR extended-release capsules, the trusted therapeutic choice for Irritable Bowel Syndrome (IBS) patients. We provide a precise explanation of uses, dosages, and mechanisms of action to ensure digestive comfort and safely control spasms effectively.

Quick Facts About the Medication

  • Scientific Name: Mebeverine Hydrochloride (200 mg).
  • Pharmaceutical Form: Hard extended-release capsules (Retard Capsules) providing 12-hour coverage.
  • Primary Indication: Treatment of Irritable Bowel Syndrome (IBS) symptoms and painful intestinal cramps.
  • Standard Dosage: One capsule twice daily (morning and evening) 20 minutes before food.
  • Key Features: Does not cause anticholinergic side effects such as dry mouth or blurred vision, making it safe for patients with glaucoma and prostate enlargement.
Box of Coloverin SR 200 mg medication for treating Irritable Bowel Syndrome.
Coloverin SR: Extended-release capsules to relieve spasms and pain of Irritable Bowel Syndrome.

Definition and Medical Uses

Coloverin SR is considered one of the cornerstones of modern internal medicine for treating functional gastrointestinal disorders. It contains the active ingredient “Mebeverine” at a concentration of 200 mg in an extended-release formulation. This substance acts as a direct antispasmodic, targeting the smooth muscles in the digestive tract—specifically in the colon area—to relax them without drastically affecting normal intestinal peristalsis. The “Extended Release” (SR) technology in this medication allows for the slow and steady release of the active ingredient throughout the day, ensuring continuous therapeutic coverage and symptom relief without the need for frequent dosing.

The most prominent and common use of Coloverin SR capsules is the management and treatment of Irritable Bowel Syndrome (IBS), a chronic condition in which the patient suffers from recurrent episodes of abdominal pain, bloating, and changes in bowel habits such as diarrhea or constipation. The medication calms colon “irritation” by blocking sodium channels and preventing calcium entry into the muscle cells of the intestines, thereby preventing the violent and painful contractions felt by the patient as cramps or colic. This direct effect makes it an ideal choice for improving the quality of life for patients suffering from anxiety and stress that directly reflect on their bowel functions.

In addition to IBS, the drug plays a pivotal role in treating secondary spasms resulting from other organic diseases in the digestive system, making it a versatile medication in internal medicine clinics. these cases include various gastrointestinal infections, diverticulitis in the colon, and its use as an adjunctive therapy to relieve pain associated with gastric and duodenal ulcers. Its therapeutic effect also extends to biliary tract and gallbladder spasms, providing relief to patients suffering from disorders in this sensitive area and reducing pain resulting from functional dyspepsia.

Clinically, Coloverin features a unique safety profile that distinguishes it from other traditional antispasmodics (such as Hyoscine or Atropine), as it does not affect the autonomic nervous system in the same way. This means patients can use it without worrying about annoying side effects like severe dry mouth, urinary retention, blurred vision, or heart palpitations. This property makes it the preferred and safe treatment for special patient groups, specifically the elderly, patients with prostate enlargement, and those with glaucoma, who are usually prohibited from using traditional antispasmodics.

  • Treatment of primary IBS symptoms such as colic, bloating, and bowel movement changes.
  • Relief of pain associated with diverticulitis and organic colon diseases.
  • Adjunctive therapy in cases of gastrointestinal infections and enteritis (dysentery).
  • Control of postoperative spasms in the digestive tract or after cholecystectomy (gallbladder removal).
  • Relief of symptoms of mucous colitis and spasmodic esophagitis/duodenitis.
  • Safe use for heart, glaucoma, and prostate patients due to the absence of atropine-like effects.

Bottom Line: Coloverin SR is considered a smart therapeutic solution combining potent intestinal pain relief with high safety, making it the first choice for doctors to control chronic and acute abdominal pain without exposing the patient to the risks of systemic side effects.

Method of Administration and Prescribed Dosages

Adhering to the correct dosage and timing is key to obtaining maximum effectiveness from Coloverin SR, as the capsules are designed to work with sustained-release technology. The standard dosage for adults is one 200 mg capsule taken twice daily, once in the morning and once in the evening, with an interval of approximately 12 hours. It is very important to take the capsule about 20 minutes before a main meal (breakfast and dinner), because the presence of food in the stomach later helps transport the medication to the intestines at the right time to start its effect before digestion—which triggers spasms—begins.

The method of taking the capsule is as important as the timing; the capsule must be swallowed whole with a large glass of water (at least 100 ml) to facilitate its passage to the stomach. It is strictly forbidden to open the capsule, chew it, or crush the granules inside, as this destroys the “Extended Release” (SR) mechanism. This would cause a large dose of the drug to rush into the blood at once rather than gradually, reducing the duration of effectiveness and increasing the likelihood of immediate side effects. Water is the preferred liquid for swallowing, and very hot or carbonated drinks should be avoided at the moment of taking the medication.

In some acute cases or at the beginning of treatment, the attending physician may recommend adjusting the dose for a short period to control severe symptoms, potentially reaching three capsules daily in exceptional cases under strict medical supervision. However, once the desired response is achieved and the colon condition stabilizes, the doctor can gradually reduce the dose and withdraw the medication after several weeks of symptom improvement. Sudden discontinuation is not recommended if treatment has been ongoing for a long time; it is always preferable to coordinate with the doctor to ensure symptoms do not rebound.

If a dose is forgotten, there is no need for worry or panic. It can be taken as soon as it is remembered if the time is still far from the next dose. However, if the time for the next dose is approaching, the forgotten dose should be skipped entirely, and the regular schedule continued without doubling the dose to compensate. An excessive overdose could theoretically excite the central nervous system, so strictly adhere to the specified amounts and do not exceed them thinking it will accelerate the healing process.

  • Standard Dosage: One capsule (200 mg) every 12 hours (morning and evening).
  • Ideal Timing: At least 20 minutes before eating to ensure effectiveness.
  • The capsule must be swallowed whole without chewing or emptying its contents to maintain its extended effect.
  • Drink plenty of water (a full glass) with the medication to facilitate swallowing and dissolution.
  • Treatment duration is determined by the doctor, and the dose is often reduced gradually after symptoms improve.

Important Warning: Adhering to the pre-meal timing is part of the treatment; the medication works to proactively calm the intestines before the arrival of food, which is the main trigger for colon spasms.

Potential Side Effects

Coloverin SR features an excellent safety profile. Clinical studies and the internal leaflet indicate that, at standard therapeutic doses, significant side effects do not occur in the vast majority of users. This is due to the drug’s selective mechanism of action, which targets intestinal muscles without affecting other body systems, sparing the patient from traditional antispasmodic symptoms like dry mouth, constipation, or urinary retention. This good tolerance makes it suitable for long-term use in chronic conditions like IBS.

Although extremely rare, allergic reactions may appear in a very small percentage of patients with hypersensitivity to Mebeverine. These reactions usually manifest as skin symptoms such as a mild rash, redness, or itching in various parts of the body (urticaria). These symptoms are often mild and temporary, disappearing once the medication is stopped and simple antihistamines are used if necessary.

In extremely rare cases, documented as isolated incidents, allergic reactions may develop into what is known as Angioedema—sudden swelling that may affect the face, lips, or tongue. This condition requires immediate discontinuation of the drug and seeking medical advice. However, it must be emphasized that this is not a common symptom and should not cause concern for the average user, but is mentioned for the sake of comprehensive scientific and medical honesty.

Aside from allergic reactions, the drug generally does not cause effects impacting mental ability or concentration, nor does it cause drowsiness, meaning it does not interfere with driving or operating machinery. It also does not significantly cause stomach upset or nausea compared to other gastrointestinal medications. The body eliminates drug metabolites via urine completely and safely, and there is no evidence of harmful accumulation in the body over the long term.

  • Appearance of mild skin rash or redness (Rare).
  • Skin itching or urticaria in hypersensitive individuals.
  • Swelling of the face or lips (Angioedema) – Very rare and requires stopping the medication.
  • Does not cause “atropine-like” side effects such as dry mouth or blurred vision.
  • Very minor digestive disturbances may occur at the start of treatment and resolve spontaneously.

Safety Summary: Coloverin SR is very safe for the vast majority of patients. If you notice any facial swelling or difficulty breathing after taking it, stop use immediately and head to the nearest medical center (a very rare occurrence).

Medical Warnings and Precautions

The main and most important contraindication for using Coloverin SR is a known history of hypersensitivity to the active ingredient (Mebeverine) or any of the inactive ingredients in the capsule. If any previous signs of allergy to this drug appear, the doctor must be informed so a therapeutic alternative from a different drug class can be prescribed. Attention should also be paid if there is severe allergy to certain sugars if the capsule contains lactose or sucrose as excipients (depending on the manufacturer), although this rarely causes problems except in cases of severe intolerance.

Regarding pregnancy and breastfeeding, Mebeverine is classified among medications preferably avoided during pregnancy, especially in the first trimester, as a precautionary measure due to the lack of sufficient studies confirming absolute safety for the fetus, despite no proven harm in animal trials. The same applies to the breastfeeding period; it is advised not to use it unless the doctor deems the expected benefit to the mother outweighs any potential risks, and usually, safer and more reliable alternatives are sought during these sensitive periods.

Patients with severe liver or kidney insufficiency should take the medication with caution and under medical supervision. Although the drug is metabolized and excreted safely, severe insufficiency in these organs may affect how the body eliminates the drug, potentially requiring dosage adjustments. Regarding patients with “Porphyria” (a rare genetic blood disease), it may be advised to avoid Mebeverine as a preventive measure, as it is sometimes classified among drugs not entirely safe for this very rare group of patients.

Regarding age, the safety and efficacy of this concentration (200 mg extended-release) have not been sufficiently established in children and adolescents under 18 years of age. Lower concentrations (like 135 mg) or other pharmaceutical forms suitable for younger ages are usually available if needed. Therefore, it is advised to restrict the use of Coloverin SR capsules to adults only and not administer them to children without consulting a specialized pediatrician to determine the appropriate dose for the child’s size and weight.

  • Contraindicated for those with previous sensitivity to Mebeverine.
  • Not recommended during pregnancy and breastfeeding unless absolutely necessary and ordered by a doctor.
  • Use with caution in patients with acute renal or hepatic impairment.
  • Not intended for children and adolescents under 18 years (more suitable alternatives exist).
  • Caution required for patients with Acute Porphyria (rare genetic disease).

Medical Advice: Always inform your doctor about all medications and nutritional supplements you are taking, as well as if you are planning pregnancy, to ensure the safest treatment plan is prescribed for you.

Frequently Asked Questions (FAQ)

1. What is the difference between Coloverin A, Coloverin D, and Coloverin SR?

Coloverin SR contains only “Mebeverine” in a high concentration and extended-release form to treat spasms all day. Coloverin A contains an additional sedative for anxiety (Chlordiazepoxide), while Coloverin D contains a gas-expelling agent (Dimethicone).

Practical Tip: If your main problem is constant cramps, Type SR is best. If bloating is severe, Type D is more suitable. If nervous tension is the main cause, the doctor might prescribe Type A for a short period.

2. Can Coloverin SR be taken continuously for long periods?

Yes, the drug is considered safe for long-term use under medical supervision for treating chronic conditions like IBS. It does not cause addiction and does not lose effectiveness over time (tolerance), making it a good choice for chronic patients.

Practical Tip: Despite its safety, it is always preferable to try reducing the dose or stopping during symptom-free periods, relying on diet regulation and lifestyle as a first line of defense, using the medication when needed or during flare-ups.

3. Does this medication affect blood pressure or the heart?

Mebeverine usually does not affect blood pressure or heart rate, nor does it cause heart rhythm problems, because it does not possess “atropine” properties that accelerate the heart. It acts very selectively on intestinal muscles only.

Practical Tip: You can use it safely if you are a blood pressure or heart patient, but as a general rule, always consult your cardiologist before adding any new medication to your routine.

4. When does the capsule start working and how long does it last?

The effect usually begins within 20 to 60 minutes of taking the capsule. Thanks to the Extended Release (SR) technology, drug release and effect continue for up to 12 hours, covering the patient throughout the day with just two doses.

Practical Tip: For the best result, take the dose 20 minutes before eating, so the medication is ready to work when food reaches the intestines, preventing pain before it happens.

5. Does Coloverin permanently cure IBS?

No medication cures IBS “permanently” because it is a chronic syndrome linked to body nature and psychological state. Coloverin treats “symptoms” highly effectively, removing pain and cramps and improving quality of life, but it does not eliminate the existence of the syndrome.

Practical Tip: Consider the medication part of a comprehensive plan that includes avoiding irritating foods (like legumes and spicy food), drinking water, exercising, and managing stress.

6. Does the medication cause constipation or diarrhea?

Coloverin is neither a laxative nor a constipating agent per se. It is a bowel movement “regulator”; if movement is too fast (diarrhea), it calms it, and if it is contracted causing retention (spastic constipation), it relaxes it. Its goal is achieving normal movement.

Practical Tip: If you suffer from severe chronic constipation, you may need additional laxatives or increased fiber alongside Coloverin, as the drug releases the spasm but does not soften the stool.

7. What should I do if I forget a dose?

If you forget the dose and remember it well before the next dose, take it immediately. If the time for the next dose is close, skip the forgotten dose completely and take the next dose on time.

Practical Tip: Never double the dose (taking two capsules together) to make up for what you missed, as this will not help and may increase the risk of side effects.

8. Does the medication interact with other drugs?

Generally, there are no serious known drug interactions for Mebeverine, making it safe to use with most other medications. However, theoretically, the absorption of some drugs might be affected due to changes in bowel movement speed.

Practical Tip: As a general precautionary measure, try to space Coloverin and any other medications by at least one hour to ensure proper absorption of each drug.

9. Does Coloverin cause weight gain?

No, there is no scientific evidence linking Mebeverine to direct weight gain. The drug does not affect hormones or fat burning processes and does not chemically increase appetite.

Practical Tip: Sometimes, when abdominal pain and bloating disappear, the patient’s appetite may improve, and they return to eating normally, which might lead to healthy weight gain due to pain relief, not the drug itself.

10. How should the medication be stored?

Coloverin SR capsules should be stored at room temperature (below 30°C), in a dry place away from direct moisture and sunlight. Bathrooms and kitchens are unsuitable places for storage due to temperature and humidity fluctuations.

Practical Tip: Keep the blister strip inside the carton to protect it from light, always check the expiration date on the strip before use, and keep it out of reach of children.

Medical Disclaimer:

The information contained in this guide is intended for educational and instructional purposes only and does not in any way substitute for consulting a specialist doctor or pharmacist. This information has been updated according to the latest medical standards available as of October 2025. Do not rely on digital content to diagnose your condition or determine your treatment yourself. If you feel any emergency medical symptoms, please proceed immediately to the nearest emergency center.

References and Sources

Dr. Ahmad Baker

Dr. Ahmad Baker, PharmD

Senior Pharmacist & Health Educator

With over 23 years of clinical experience in hospital and community pharmacy across Egypt and Saudi Arabia, Dr. Ahmad specializes in reproductive health and pharmaceutical safety. He is dedicated to providing evidence-based guidance to empower patients in the MENA region.

Medical Disclaimer: This content is for educational purposes and reflects the latest pharmaceutical protocols. It is not a substitute for personal medical advice. Always consult Dr. Ahmad Baker or your healthcare provider before starting any treatment.